It's widely known that Ca^2+^ represents one of the most important second messengers in the brain and plays an essential role in neuronal development, synaptic transmission and plasticity, besides regulating various metabolic pathways ([@B20]). The regulation of Ca^2+^ homeostasis in the central nervous system is a very complex process involving proteins localized in the plasma membrane, endoplasmic reticulum (ER), mitochondria, and cytoplasm that together are responsible for maintaining a higher concentration of Ca^2+^ in the extracellular space ([@B3]). Notably, as demonstrated by several studies, a dysregulation in Ca^2+^ homeostasis is associated with many pathological mechanisms, especially those related with neurodegenerative disorders ([@B2]; [@B21]).

Based on previous observations that intracellular Ca^2+^ levels are increased in aging neurons, it has been suggested that a dysregulation of Ca^2+^ homeostasis could be a key step in the pathogenesis of Alzheimer's disease (AD; [@B18]). In fact, this is the basis of the calcium hypothesis of AD, which offers a potential correlation between β-amyloid (Aβ) toxicity and a progressive decline in memory and neuronal cell death ([@B10]). The central idea is that activation of the amyloidogenic pathway leads to a remodeling of the neuronal Ca^2+^ signaling, and this remodeling usually appears as upregulated in AD, triggered by either an enhance in the entry of external Ca^2+^ or a release from internal stores ([@B1]).

The Aβ peptide, present in the extracellular senile plaques, is one of the hallmarks of the disease and its aggregation in oligomers has been found to induce Ca^2+^ influx into neurons functioning as channels and/or by activating channels in the plasma membrane ([@B7]). The Aβ oligomers could form non-selective pores with high conductance for Ca^2+^ but they could also alter the fluidity of the membrane affecting the activity of several Ca^2+^ permeable channels, including acetylcholine receptors, glutamate receptors, dopamine receptors, and serotonin receptors ([@B9]). On the other hand, within the neurons, Aβ interacts with two types of Ca^2+^ channels in the ER membrane that regulate calcium release from internal stores: (i) ryanodine receptors (RyRs) and (ii) inositol trisphosphate receptors (IP3Rs); this leads to an increase of their opening and the amount of Ca^2+^ being released by the ER ([@B6]). It is relevant to note, though, that data from literature demonstrate that genetic factors may be crucial in the dysregulation of Ca^2+^ homeostasis in AD. Presenilins mutations, which are known to cause the familial form of AD, have been found to increase the release of intracellular Ca^2+^ from internal stores ([@B14]; [@B5]). The activity of the SERCA pump, which is responsible for maintain the Ca^2+^ concentration gradient across the ER membrane (higher inside) is enhanced by the presenilins ([@B11]). Additionally, there is increasing evidence that presenilins may be leak channel. [@B22] reported that the mutated form of presenilin 1 (*PS1*) reduces the passive leak in neurons resulting in an increase of cytoplasmatic Ca^2+^.

Of particular interest, it was demonstrated that a polymorphism in *CALHM1* (Ca^2+^ homeostasis modulator-1) was significantly associated with the sporadic form of the disease in a case-control study ([@B8]). Based on its sequence similarity to the ionotropic glutamate receptor NMDA, it has been proposed that this gene encodes a glycoprotein that is a cerebral Ca^2+^ channel component, which is localized both in the plasma membrane and ER, and may also function as a leak channel ([@B8]). The expression of *CALHM1* polymorphic variant reduces Ca^2+^ entry and this reduced Ca^2+^ permeability would increase the level of stored Ca^2+^ by reducing this putative leak pathyway; consequently, a decreased intracelullar Ca^2+^ levels is observed ([@B8]). The authors also suggest a direct impact of *CALHM1* on Aβ production. Although some studies argue against the latter observation, it seems that the problem is the different methods used for analysis of the data ([@B4]; [@B17]). Besides, even though it seems controversial that in the familial form of AD an increase of intracellular Ca^2+^ is observed while in the sporadic form studies report a reduce in intracellular Ca^2+^ levels, dysregulation of Ca^2+^ homeostasis in the two forms of AD, as described above, arise by different mechanisms, but what is pretty clear in the literature is that dysregulation of Ca^2+^ homeostasis is a major feature in AD.

More recently, a multicenter study reported a robust and consistently significant enrichment for genes constituting the calcium signaling pathway, especially those related to the elevation of cytosolic calcium, in independent cohorts of young and elderly participants ([@B13]). The authors also showed that the same gene set identified in those participants was significantly enriched in a very large case-control study of sporadic AD, making evident that calcium signaling is crucial in human memory processes, both in cognitive health and disease ([@B13]).

In an investigation about the frequency of DNA copy number variations (CNVs) in a cohort of 46 individual's diagnosed post-mortem with late-onset AD provided by the Brain Bank of the Brazilian Aging Brain Study Group (BBBABSG; [@B12]). We found two cases with rare microduplications partially or fully affecting genes that encode different subunits of the same type of voltage-gated Ca^2+^ channels, the L-type (L-VGCC). One individual presented a genomic imbalance of 665 kb at 3p21.1 that incudes, among other genes, *CACNA1D* and *CACNA2D3* (**Figure [1A](#F1){ref-type="fig"}**). *CACNA1D* encodes the subunit α1 (subtype ~1D~), which form the ion-conducting pore of the L-VGCC, and *CACNA2D3* is responsible for encoding the subunit α-2δ, that influences the channels' biophysical properties by increasing the current amplitude and regulating the activation and inactivation kinetics of the L-VGCC. On the other hand, the other subject showed a genomic imbalance of 300 kb at 3p21.31 that encompass the *CACNA2D2* gene, which acts similarly to *CACNA2D3*, i.e., also encodes the subunit α-2δ of the L-VGCC (**Figure [1B](#F1){ref-type="fig"}**). Both duplications have intragenic breakpoints; depending on the resulting structure of the rearrangement, the partial gene duplications can result in loss of function of the genes involved.

![**Rare copy number variations (CNVs) implicated in voltage gate calcium channels detected in two individuals with late-onset Alzheimer's disease.** The figure shows array-CGH results where each dot represents a probe. A genomic segment was considered duplicated or deleted when the log~2~ ratio of the Test/Reference fluorescent intensities of a given region encompassing at least three probes was above 0.3 or below -0.3, respectively, (Images were extracted from Genomic Workbench software). **(A)** Top shows array-CGH profile of chromosome 3 of Individual 1; the black box indicates the location of the microduplication on the short arm of the chromosome; underneath a detailed view of the area comprised in the black box at 3p21.1; the image shows a 665 kb duplication containing among other genes, *CACNA1D* and *CACNA2D3*, highlighted by a blue trace. **(B)** Top shows array-CGH profile of chromosome 3 of Individual 2; the black box indicates the location of the microduplication on the short arm of the chromosome; underneath a detailed view of the area comprised in the black box at 3p21.31; the image shows a 300 kb duplication containing among other genes, *CACNA2D2*, highlighted by a blue trace.](fgene-07-00107-g001){#F1}

To exclude that these rare CNVs (rare defined as frequency \<0.1% of population, based on the Database of Genomic Variants -- DGV) represent common variants in the Brazilian population, we compile CNV data from more than 1,300 individuals studied by array-CGH in our laboratory for reasons other than dementia, such as cancer predisposition, deafness, congenital abnormalities, and intellectual disability. The rare CNVs documented in this study were never detected in any of these subjects. Additionally, in contrary to the control sample in this study, which consisted in individuals with no anatomophatological signs of AD, this set of more than 1,300 individuals is supposedly similar to the population regarding AD predisposition factors. In particular, despite some of the other individuals investigated in our casuistic also presented rare CNVs, these two cases are the only ones who showed copy number changes in genes that constitute the calcium signaling pathway. However, we cannot exclude that the remaining 44 individuals may have point mutations in relevant genes of calcium signaling pathway that could not be observed due to a limited resolution of array-CGH.

CNVs are recognized to be a prevalent form of common genetic variation and represent a substantial proportion of total genetic variability in human population. The functional impact of CNVs has been demonstrated at all biological levels, from cellular effects on gene expression to their association with several types of complex traits and genetic diseases ([@B19]). To date, copy number changes in genes encoding calcium-signaling molecules have been associated especially with neuronal development disorders, such as autism ([@B16]), psychiatric diseases ([@B15]), and amyotrophic lateral sclerosis.

The present evidence is the first to highlight genomic imbalances in genes that are known to encode important calcium-signaling molecules, and link those CNVs to late-onset AD. Of note, in the manuscript from [@B13] it was demonstrated that the same gene family of *CACNA1D*, *CACNA2D2*, and *CACNA2D3* was found to be significantly enriched in patients with AD, which reinforces the significance of our findings. The present data also contribute adding new mutations in genes of calcium signaling pathway and associate these mutations with AD since *CACNA1D*, *CACNA1D*, *CACNA2D2*, and *CACNA2D3* are not in the list of genes studied by [@B13]. Thus, considering the importance of L-VGCC in the central nervous system and Ca^2+^ being such an important regulator of synaptic plasticity, we could suppose that a disruption in *CACNA1D*, *CACNA2D3*, and *CACNA2D3* caused by CNVs may lead to a dysregulation in Ca^2+^ homeostasis and contribute to the pathogenesis of AD. Also, using the Variant Effect Predictor (VEP) tool from Ensemble^[1](#fn01){ref-type="fn"}^ to predict the effects of these two microduplications on genes, transcripts, and protein sequence, as well as regulatory regions, we found that the most likely consequence (34%) is amplification of the amount of transcript. Therefore, this prediction suggests a possible upregulation of Ca^2+^ signaling, which meets the central idea of the calcium hypothesis of AD ([@B1]). Yet, the crucial question of whether the microduplications showed in this study constitutes a predisposing risk factor for AD can only be answered by similar investigations in large cohorts, which we hope will be stimulated by this report. Also, we believe that the present evidence may stimulate further functional studies and eventually confirm the impact of these copy number changes in the pathogenesis of AD.

In summary, we wish to draw attention to rare DNA CNVs identified in two subjects with late-onset AD that led to partial or full duplication of genes that encode different subunits of the same type of voltage-gated Ca^2+^ channels and point out that the present finding is consistent with the critical role of calcium signaling in molecular processes underlying memory as has been demonstrated by several studies.
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